http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-MI982299-D0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89b60e340c7765626013119f28c35bfd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_405ab5851ff71494b1eb9cd9bd706f18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6727c1581f78ef559672284e805654d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db0d02e06abbd42dbc78de355d87eb9b
publicationDate 1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IT-MI982299-D0
titleOfInvention USE OF OTILONIUM BROMIDE AS AN NK2 ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
priorityDate 1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453502507

Total number of triples: 13.